Repurposing anticonvulsants for treatment of injury-induced osteoarthritis

January 3, 2018, Cardiff University

Drugs designed for the treatment of central nervous system diseases could also be used to prevent the development of injury-induced arthritis, potentially saving the NHS around half a billion pounds a year.

Dr. Deborah Mason and Dr. Cleo Bonnet at Cardiff University discovered that a single injection of a common anticonvulsant drug, following , could relieve pain and swelling more than any other approved therapy and vastly reduce the inflammation, and bone and cartilage destruction, that leads to .

Dr. Deborah Mason from Cardiff University's School of Biosciences and the Arthritis Research UK Biomechanics and Bioengineering Centre said: "Osteoarthritis affects around 8.5 million people in the UK and around 1 million of these cases are caused by injury.

"As these figures rise with our aging population, and put further strain on our health system, there is an urgent need to find preventative treatments."

Osteoarthritis—the most common form of joint —causes pain and disability. There are currently no disease modifying treatments for the condition, which is usually diagnosed after joint degeneration, when the disease is advanced. In many patients, osteoarthritis may have started years earlier, sometimes from an injury to their joint.

Joint injury leads to osteoarthritis in more than 50 percent of patients, usually around 5-15 years after the injury, when the only is to relieve symptoms of pain and inflammation using non-steroidal anti-inflammatory drugs (NSAIDs) or pain-killers like paracetamol.

Dr. Mason said: "We found that drugs developed for central nervous system disorders are able to prevent the release of a chemical implicated in , potentially preventing pain and the degeneration that can cause osteoarthritis years down the line."

The researchers already knew that a molecule called glutamate is released into the joint at very high concentrations in arthritis, and during joint trauma, triggering its cells to release a chemical implicated in inflammation. Their laboratory tests revealed that this process could be blocked by the NBQX which prevented the cells reacting to glutamate and releasing the inflammation-causing chemicals that cause .

The research is currently in the preclinical stage and has not yet been tested on human subjects. However, this class of drugs has been tested in humans for epilepsy, meaning that repurposing them to prevent osteoarthritis should provide a safe and fast route to clinical trials.

Explore further: Improvements in ACL surgery may help prevent knee osteoarthritis

Related Stories

Improvements in ACL surgery may help prevent knee osteoarthritis

February 21, 2017
Injury to the anterior cruciate ligament (ACL) in the knee frequently leads to early-onset osteoarthritis, a painful condition that can occur even if the patient has undergone ACL reconstruction to prevent its onset. A new ...

Drugs related to cannabis have pain-relieving potential for osteoarthritis

January 7, 2014
Chemical compounds synthesised in the laboratory, similar to those found in cannabis, could be developed as potential drugs to reduce the pain of osteoarthritis.

Chondroitin sulfate as good as widely used anti-inflammatory for knee osteoarthritis

May 23, 2017
High quality (pharmaceutical grade) chondroitin sulfate is as good as a widely prescribed non-steroidal anti-inflammatory drug (celecoxib) for the treatment of painful knee osteoarthritis, concludes research published online ...

Researchers find new genes link to arthritis in bone marrow lesions

July 18, 2017
Researchers have found a pattern of genes which is characteristic of osteoarthritis and may be a step towards better treatments for this condition.

New therapeutic targets for osteoarthritis pain

August 26, 2017
A new review by David A. Walsh and Joanne Stocks in the September 2017 issue of SLAS Discovery (formerly the Journal of Biomolecular Screening) explores evolving treatments and future therapies for osteoarthritis (OA) pain.

Recommended for you

More doctor visits lead to less suicide attempts for fibromyalgia patients

September 19, 2018
Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.

Antioxidant found to be effective in treating mice with osteoarthritis

September 14, 2018
A team of researchers in Belgium and the Netherlands has found that feeding a common antioxidant to test mice was effective in treating osteoarthritis. In their paper published in Science Translational Medicine, the group ...

Researchers find answers as to why some people are at risk of gout

September 12, 2018
University of Otago researchers have helped characterise a genetic variant that enables new understanding of why some people are at risk of gout, a painful and debilitating arthritic disease.

Emotions like anger and sadness may cause pain as well as being a result of it

September 10, 2018
While emotions such as anger or sadness are often thought of as being a result of stress or pain, findings recently published by Penn State researchers suggest that negative or mixed emotions could function as stressors themselves.

Dietary carbohydrates could lead to osteoarthritis, new study finds

August 9, 2018
Do your knees ache? According to new findings from the Oklahoma Medical Research Foundation, your diet could be a culprit.

Joint study raises questions about treatments for arthritis

August 3, 2018
A study examining how molecules are transported into knee-joint tissue could have major implications for understanding and treating arthritis.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.